Add Company
Join Now

Young Pharmaceuticals Revenue and Competitors

License our Company Data API

Wethersfield, CT

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Young Pharmaceuticals's estimated annual revenue is currently $6M per year.(i)
  • Young Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Young Pharmaceuticals has 30 Employees.(i)
  • Young Pharmaceuticals grew their employee count by 0% last year.

Young Pharmaceuticals's People

NameTitleEmail/Phone
1
VP SalesReveal Email/Phone
2
Regional Marketing DirectorReveal Email/Phone
3
Production ManagerReveal Email/Phone
4
Regional Marketing ManagerReveal Email/Phone
5
Regional Marketing ManagerReveal Email/Phone
6
Sales RepresentativeReveal Email/Phone
7
Sales SpecialistReveal Email/Phone
8
Pharmaceutical Sales RepresentativeReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$22.9M11424%N/AN/A
#2
$1105.9M55023%N/AN/A
#3
$47M23426%N/AN/A
#4
$9.2M465%N/AN/A
#5
$10192.5M507093%N/AN/A
#6
$6M300%N/AN/A
#7
$110.1M5489%N/AN/A
#8
$8.8M44-2%N/AN/A
#9
$21.3M106-27%N/AN/A
#10
$27.7M138-28%N/AN/A
Add Company

What Is Young Pharmaceuticals?

Young Pharmaceuticals, Inc. was founded in 1977 as a developer of products for dispensing dermatologists. Our initial line included topicals for a variety of general dermatologic conditions. As ingredients became available for such indications as photo-aging, our scientists applied their pharmaceutical chemistry experience to formulating and pioneering a new generation of aesthetic treatments. Today, Young remains committed to providing high-quality medical skin care products to dispensing physicians worldwide. Young specializes in private labeling, and are not sold on line.

keywords:N/A

N/A

Total Funding

30

Number of Employees

$6M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A303%N/A
#2
$4.2M320%N/A
#3
$6.6M395%N/A
#4
$10.4M40N/AN/A
#5
$10.3M4021%N/A